Wieland H. Sommer1, Marco Armbruster1, Steven Sourbron1, Maximilian F. Reiser1, Christoph Zech1
1Department of Clinical Radiology, University of Munich, Grohadern Hospital, Munich, Bavaria, Germany
A dynamic contrast enhanced MRI protocol for the liver was established in neuroendocrine tumors with liver metastases. To find the clinical value of DCE-MRI parameters, these were correlated with FDG-PET-CT parameters and clinical parameters. We found that the arterial plasma flow highly correlates with SUV vales from PET-CT and therefore can monitor the metabolism of the metastases. Other parameters correlated with tumor markers or clinical outcome parameters.